A recall of the opioid overdose antidote naloxone was announced on Monday.
The US Food and Drug Administration said the recall was caused by the possibility of “looseness of particulate matter on the syringe plunger,” which could pose many health risks. CNN report.
The agency has not received any reports of harm to the patient from the recalled naloxone created by Hospira.
The recall was distributed to wholesalers, distributors and hospitals in the United States, Puerto Rico and Guam between February and February 2017, with lot numbers 72680LL and 76510LL of 0.4 mg / ml, 1 mL, 2.5 mL strength. For single-use sterilization cartridge units. 2018, CNN report.
Hospira said distributors and retailers should not use or distribute recalled naloxone and should warn stores, pharmacies, hospitals, and others who receive it.
Copyright © 2018 Health Day. all rights reserved.
Recall of opioid antidote naloxone
Source link Recall of opioid antidote naloxone